Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2026-03-20 @ 3:45 AM
Study NCT ID:
NCT06773195
Status:
RECRUITING
Last Update Posted:
2025-12-12
First Post:
2025-01-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
24-157
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None